Cargando…
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
ASXL1 mutations occur frequently in myeloid neoplasms and are associated with poor prognosis. However, the mechanisms by which mutant ASXL1 induces leukaemogenesis remain unclear. In this study, we report mutually reinforcing effects between a C-terminally truncated form of mutant ASXL1 (ASXL1-MT) a...
Autores principales: | Asada, Shuhei, Goyama, Susumu, Inoue, Daichi, Shikata, Shiori, Takeda, Reina, Fukushima, Tsuyoshi, Yonezawa, Taishi, Fujino, Takeshi, Hayashi, Yasutaka, Kawabata, Kimihito Cojin, Fukuyama, Tomofusa, Tanaka, Yosuke, Yokoyama, Akihiko, Yamazaki, Satoshi, Kozuka-Hata, Hiroko, Oyama, Masaaki, Kojima, Shinya, Kawazu, Masahito, Mano, Hiroyuki, Kitamura, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048047/ https://www.ncbi.nlm.nih.gov/pubmed/30013160 http://dx.doi.org/10.1038/s41467-018-05085-9 |
Ejemplares similares
-
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
por: Nagase, Reina, et al.
Publicado: (2018) -
ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation
por: Saika, Makoto, et al.
Publicado: (2018) -
Opposing effects of acute versus chronic inhibition of p53 on decitabine’s efficacy in myeloid neoplasms
por: Tamura, Moe, et al.
Publicado: (2019) -
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
por: Fujino, Takeshi, et al.
Publicado: (2021) -
CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression
por: Liu, Xiaoxiao, et al.
Publicado: (2022)